Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M405Revenue (TTM) $M20.4Net Margin (%)-339.6Altman Z-Score-10.3
Enterprise Value $M346EPS (TTM) $-0.7Operating Margin %-342.2Piotroski F-Score1
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-339.6Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsN
Price/Sales13.55-y EBITDA Growth Rate %-14.4Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-68.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-95.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M122ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RIGL is held by these investors:



RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Duliege Anne-MarieChief Medical Officer 2017-01-03Sell5,000$2.4123.65view
PAYAN DONALD GEVP, Pres. Discovery&Research 2016-08-30Sell5,303$4-25.5view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-06-10Sell41,666$3.68-19.02view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-04-01Sell10,000$3.75-20.53view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2234.23view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2234.23view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.5616.41view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-19.68view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.6412.88view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-14.12view

Quarterly/Annual Reports about RIGL:

News about RIGL:

Articles On GuruFocus.com
Rigel Announces Tavalisse™ as Proprietary Name for Fostamatinib in the United States Apr 27 2017 
Rigel Announces Conference Call and Webcast to Report First Quarter 2017 Financial Results Apr 25 2017 
Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP Apr 17 2017 
Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

More From Other Websites
Rigel Announces Tavalisse™ as Proprietary Name for Fostamatinib in the United States Apr 27 2017
Rigel Announces Conference Call and Webcast to Report First Quarter 2017 Financial Results Apr 25 2017
Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug Apr 18 2017
Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP Apr 17 2017
5 Top Breakout Stocks to Boost Your Portfolio Mar 31 2017
Increased Earnings Estimates Seen for Rigel (RIGL): Can It Move Higher? Mar 27 2017
After Years of Stagnation, Are Shares of Rigel Pharmaceuticals About to Take off Into the... Mar 24 2017
Will Rigel Pharmaceuticals (RIGL) Continue to Surge Higher? Mar 24 2017
3 Beaten-Up Biotech Stocks: Are They Bargains? Mar 21 2017
3 Stocks That Are Ridiculously Cheap Right Now Mar 20 2017
5 Cheap Breakout Stocks for Superb Returns Mar 16 2017
Rigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Mar 09 2017
Edited Transcript of RIGL earnings conference call or presentation 7-Mar-17 10:00pm GMT Mar 08 2017
Rigel reports 4Q loss Mar 07 2017
Rigel Announces Fourth Quarter 2016 and Year End 2016 Financial Results and Provides Company Update Mar 07 2017
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2016 Financial... Feb 28 2017
3 Cheap Healthcare Stocks You Can Buy Right Now Feb 24 2017
Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase... Feb 03 2017
Rigel Announces Pricing Of Public Offering Of Common Stock Jan 31 2017
Rigel Announces Proposed Public Offering Of Common Stock Jan 30 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)